Taxanes for advanced non-small cell lung cancer (Protocol)
Fecha
2018
Profesor Guía
Formato del documento
Articulo
ORCID Autor
Título de la revista
ISSN de la revista
Título del volumen
Editor
Cochrane
ISBN
ISSN
item.page.issne
item.page.doiurl
Departamento o Escuela
Escuela de Medicina
Determinador
Recolector
Especie
Nota general
Resumen
This is a protocol for a Cochrane Review (Intervention). The objectives are as follows:
To assess the effects of taxanes as part of a combined or single‐agent therapy versus other agents or best supportive care as first‐ or second‐line treatment for advanced non‐small cell lung cancer (NSCLC). A secondary objective is to assess different modes or schemes of administration of taxanes in patients with this disease.